Navigation Links
Digirad Names Richard B. Slansky Chief Financial Officer
Date:2/17/2009

POWAY, Calif., Feb. 17 /PRNewswire-FirstCall/ -- Digirad Corporation (Nasdaq: DRAD), a leading provider of diagnostic imaging products, and personnel and equipment leasing services, today announced that it has named veteran financial executive Richard B. Slansky as Chief Financial Officer of the Company, effective March 9, 2009, replacing Interim Chief Financial Officer Todd Clyde, who will continue to serve as President and Chief Executive Officer.

With more than 25 years of experience as a Chief Financial Officer at both public and private companies, Slansky, 51, has served for the past six years as the President and Chief Financial Officer of Poway, Calif.-based SpaceDev, Inc., a publicly traded space technology/aerospace company acquired by privately held Sierra Nevada Corporation in December.

Clyde said, "Richard has the breadth of background and expertise that will make him a key part of the Digirad executive team. His financial background and strong performance record of improving efficiency and supporting organizational growth will be critical as we progress toward consistent profitability and positive cash flow while further penetrating our markets. We look forward to welcoming Richard to the senior management team and to the positive contributions he will bring to the role."

Prior to SpaceDev, Slansky served as Interim Chief Financial Officer for Woodlands, Tex.-based Quick Strike Resources. He has also served as Chief Financial Officer at Path 1 Network Technologies, Inc; Nautronix, Inc.; Alexis Corporation; and Calbiochem-Novabiochem International (aka C-N Biosciences), all located in the greater San Diego, Calif. area.

He received a Master's in Business Administration from the University of Arizona and a bachelor's degree in Economics from the University of Pennsylvania. Slansky also completed select continuing education courses for the California Council for Quality and Service Board of Examiners, American Society of Quality Control's ISO 9000 Implementation, San Diego State University's Executive Challenge Program and the American Management Association's Course for Presidents. He currently resides in Poway, Calif.

About Digirad Corporation

Digirad provides medical diagnostic imaging systems and personnel and equipment leasing services to physicians' offices, hospitals and imaging centers for cardiac, vascular, and general imaging applications. Digirad's Cardius XPO line of nuclear imaging cameras use patented solid-state technology and unique multi (single, dual, triple) head design for superior performance and advanced features for sharper digital images, faster processing, compact size, lighter weight for portability, ability to handle patients up to 500 pounds, and improved patient comfort compared to standard nuclear cameras. Digirad's 2020tc general-purpose nuclear imager has a small footprint and may also be configured for fixed or mobile use to supplement primary imaging. Digirad's installed base of equipment exceeds 600 systems; in addition, a mobile fleet of more than 145 nuclear and ultrasound imaging systems is being used in 21 states, primarily in the eastern, midwestern and southwestern United States. For more information, please visit www.digirad.com. Digirad(R), Digirad Imaging Solutions(R), and Cardius(R) are registered trademarks of Digirad Corporation.

Forward-Looking Statements

This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995. These include statements regarding the efficacy of Digirad's centers of influence model, the status of the negotiation of the sale or closure of underperforming hub locations, and the ability to achieve positive cash flow and profitability, drive technology progress and improve services utilization to grow market share. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the statements made, including the risks associated with changes in business conditions, technology, customers' business conditions, work force, suppliers, business prospects, economic outlook, operational policy or structure, acceptance and use of Digirad's camera systems and services, reliability, recalls, and other risks detailed in Digirad's filings with the U.S. Securities and Exchange Commission, including Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other reports. Readers are cautioned to not place undue reliance on these forward looking statements, which speak only as of the date hereof. All forward looking statements are qualified in their entirety by this cautionary statement, and Digirad undertakes no obligation to revise or update the forward looking statements contained herein.

    Investor Contact:
    Matt Clawson
    Allen & Caron
    949-474-4300
    Matt@allencaron.com

    Company Contact:
    Todd Clyde, CEO
    858-726-1600
    ir@digirad.com


'/>"/>
SOURCE Digirad Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Digirad Corporation Sells Northern California Service Hubs
2. Digirad Corporation to Release Fourth Quarter and Year-End Financial Results on February 5, 2009
3. Digirad Corporation Comments on Fourth Quarter Progress
4. Digirad Corporation CEO to Present at J.P. Morgan Healthcare Conference in San Francisco
5. Digirad Corporation Receives FDA 510(k) Clearance for nSPEED(R) Reconstruction Software for Improved Image Quality in Less Time With Less Radiation
6. Digirad Corporation Reports Financial Results for 2008 Second Quarter and Six Months
7. Digirad Corporation to Present at CapStone Small-Cap Investor Conference
8. Digirad Corporation to Present at Bank of America 2008 Health Care Conference
9. Digirad Corporation and University of Chicago Medical Center Sign Letter of Agreement
10. Digirad Corporation Reports Financial Results for First-Quarter 2008
11. Digirad Corporation to Release First Quarter Financial Results on April 24, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... February 28, 2017 , ... BrightStar Care Marietta announced that it has received ... Pulse. This award is granted only to top-ranking home care providers, based on client ... ranked among home care providers from across the country who have proven their ability ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... ... mass and overall body strength, which often leads to a host of health ... Journal of the American Geriatrics Society discovered that good overall muscle strength ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... Much attention ... concern for women who become dependent on opioid painkillers has fallen short. From 1999 ... compared to a 237% increase in fatal overdoses in male populations.(1) , The proportion ...
(Date:2/27/2017)... ... February 27, 2017 , ... This webinar , sponsored ... a tool to characterize particle size distributions in the field of geoscience and ... novel scientific findings. It describes methods of optimized and standardized sample collection, preparation ...
(Date:2/27/2017)... Vancouver, BC (PRWEB) , ... February 27, 2017 ... ... top drug rehabilitation and alcohol treatment programs in British Columbia, Canada, at ... (RMT) to its team. The new hire, Mackenzie Alsager, showcases the Centre's commitment ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... FRANCISCO , February 28, 2017 The global  pulse ... a new report by Grand View Research, Inc. The pulse oximeters market is ... to the growing prevalence of target diseases such as chronic obstructive pulmonary disease ... Continue Reading ... Grand View Research ...
(Date:2/28/2017)... , Feb 28, 2017 Nordic Nanovector ASA (OSE: ... 2016. A presentation of the results by the company,s senior management ... Oslo - details below. ... 2016 was a very successful year for ... development of Betalutin®, progressed with our preclinical candidates and build the ...
(Date:2/27/2017)... Ga., Feb. 27, 2017 Halyard Health, Inc. (NYSE: ... 2016 results and provided its 2017 outlook and related key ... sales were $410 million, a 2 percent increase compared to ... fourth quarter 2016 was $10 million compared to net income ... quarter adjusted net income was $24 million compared to adjusted ...
Breaking Medicine Technology: